$YHGJ Cashflow Statement | Understand Stock

$YHGJ

$2.66 +$0.15 (5.97%) Close

$YHGJ Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net loss
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating
Depreciation and amortization
Impairement of Hubei assets
Issuance of common stock for consulting services
Equity compensation charge
Amortization of ROU asset
Realized currency translation gain
Gain on forgiveness of PPP Funding
Gain on sale of building
Provision for losses on accounts receivable
Provision for losses on inventories
Impairment of Note Receivable
Deconsolidation of disposed entities
Non-cash interest and fees
Change in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Trade payables
Advance investor deposit
Operating leases
Accrued liabilities

Net cash (used in) provided by operating activities
Cash flows from investing activities:
Proceeds from Sale of building
Purchases of property, plant and equipment
Net cash (used in) provided by investing activities
Repayment of debt and revolving line of credit

Repayment of debt and revolving line of credit
Proceeds from issuance of long-term debt and revolving line of credit
Cash flows from financing activities:
Repayment of debt and revolving line of credit
Proceeds from advance from investor
Stock issuance
Cash paid for stock issuance costs
Proceeds from PPP
Cash paid for deferred financing fees
Repayment of note payable, related party
Repayment of note payable
Net advances (repayments) on revolving line of credit
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information and noncash investing and financing activities:
Cash payments for interest
Conversion of accounts payable debt to Series A Preferred
Accrued dividend and accretion on Series A and B Preferred Stock
Issuance of Placement agent warrants in connection with Series A Preferred offering
Accrued dividend and accretion on preferred stock
Lease right-of-use assets and lease liability
Conversion of Series A, C and D Preferred Stock
Issuance of Series C and D Preferred offerings
Stock Placement Agent
Total issuance of Series C and D Preferred offerings
Accretion of dividends on preferred stock
Common stock issued in exchange for assets acquired
Reduction of prepaid expense, in exchange for surrender of common stock
Allocation of proceeds from preferred stock financing to the issuance of warrants for preferred stock
Reclassification of advances upon issuances of preferred stock
Adjustment to right-of-use asset and lease liability upon extension
Conversion of notes and liabilities into common stock
Conversion of advance received from investor into common stock
Common stock issued in exchange for rent due to Icy Melon
Conversion of preferred stock into common stock
Conversion of notes and deposits into common stock
Cash receipts for tax refund
Amortization of beneficial conversion feature and deemed dividend on Series C and D Preferred stock

Comments